Parametric Portfolio Associates’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Parametric Portfolio Associates’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-78,277	Closed	-$2.16M	–	3710
2021 Q2	$2.16M	Buy	78,277 +1,387	+2%	+$27.3K	﹤0.01%	2392
2021 Q1	$1.27M	Buy	76,890 +18,912	+33%	+$431K	﹤0.01%	3044
2020 Q4	$1.07M	Sell	57,978 -17,476	-23%	-$313K	﹤0.01%	3017
2020 Q3	$1.03M	Buy	75,454 +25,397	+51%	+$392K	﹤0.01%	2904
2020 Q2	$897K	Buy	+50,057	New	+$755K	﹤0.01%	2969
2018 Q4	–	Sell	-22,165	Closed	-$222K	–	3994
2018 Q3	$222K	Buy	+22,165	New	+$258K	﹤0.01%	3720

Parametric Portfolio Associates's TBIO Position: Q3 2021 in Review

Parametric Portfolio Associates sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 78,277 shares — an estimated $2.16M sold.

Parametric Portfolio Associates first reported a position in TBIO in Q3 2018 and held it in 6 quarters. The position peaked at $2.16M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Parametric Portfolio Associates reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Parametric Portfolio Associates sold 78,277 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $2.16M.
Parametric Portfolio Associates first reported a position in Translate Bio, Inc. Common Stock in Q3 2018 and held it in 6 quarters.
Parametric Portfolio Associates's Translate Bio, Inc. Common Stock position peaked at $2.16M in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Parametric Portfolio Associates's 13F filing for Q3 2021, filed 15 Nov 2021.